TTOO

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

T2 Biosystems Inc

PINK | TTOO

0.02

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 10, 2025)

$617.00K

Market Cap

-

P/E Ratio

-0.03

EPS

$1.86

52 Week High

$0.00

52 Week Low

HEALTHCARE

Sector

TTOO Chart

Recent Chart
Price Action

TTOO Technicals

Tags:

TTOO Earnings

Yearly Income Statement (As of Dec 31, 2023)

Field Value (USD)
Gross Profit -$8.2M
Total Revenue $7.2M
Cost Of Revenue $15M
Costof Goods And Services Sold $15M
Operating Income -$50M
Selling General And Administrative $26M
Research And Development $14M
Operating Expenses $41M
Investment Income Net -
Net Interest Income -$5.7M
Interest Income -
Interest Expense $5.3M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $859K
Income Before Tax -$50M
Income Tax Expense $691K
Interest And Debt Expense -
Net Income From Continuing Operations -$50M
Comprehensive Income Net Of Tax -
Ebit -$45M
Ebitda -$44M
Net Income -$50M

Revenue & Profitability

Earnings Performance

TTOO Financials

yearly Balance Sheet (As of Dec 31, 2023)

Field Value (USD)
Total Assets $35M
Total Current Assets $25M
Cash And Cash Equivalents At Carrying Value $16M
Cash And Short Term Investments $16M
Inventory $4.8M
Current Net Receivables $1.4M
Total Non Current Assets $9.6M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments -
Other Current Assets $3.3M
Other Non Current Assets -
Total Liabilities $63M
Total Current Liabilities $56M
Current Accounts Payable $1.5M
Deferred Revenue -
Current Debt -
Short Term Debt $43M
Total Non Current Liabilities $6.7M
Capital Lease Obligations $8.2M
Long Term Debt -
Current Long Term Debt $41M
Long Term Debt Noncurrent -
Short Long Term Debt Total $49M
Other Current Liabilities $12M
Other Non Current Liabilities -
Total Shareholder Equity -$28M
Treasury Stock -
Retained Earnings -$584M
Common Stock $4K
Common Stock Shares Outstanding $2.6M

yearly Cash Flow (As of Dec 31, 2023)

Field Value (USD)
Operating Cashflow -$48M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $859K
Capital Expenditures $192K
Change In Receivables -
Change In Inventory -$744K
Profit Loss -
Cashflow From Investment -$192K
Cashflow From Financing $53M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity $0
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$50M

yearly Income Statement (As of Dec 31, 2023)

Field Value (USD)
Gross Profit -$8.2M
Total Revenue $7.2M
Cost Of Revenue $15M
Costof Goods And Services Sold $15M
Operating Income -$50M
Selling General And Administrative $26M
Research And Development $14M
Operating Expenses $41M
Investment Income Net -
Net Interest Income -$5.7M
Interest Income -
Interest Expense $5.3M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $859K
Income Before Tax -$50M
Income Tax Expense $691K
Interest And Debt Expense -
Net Income From Continuing Operations -$50M
Comprehensive Income Net Of Tax -
Ebit -$45M
Ebitda -$44M
Net Income -$50M

TTOO Profile

T2 Biosystems Inc Profile

Sector: HEALTHCARE

Industry: DIAGNOSTICS & RESEARCH

T2 Biosystems, Inc. is an innovative in vitro diagnostic company based in Lexington, Massachusetts, focused on developing cutting-edge diagnostic products for rapid and accurate detection of pathogens in the healthcare sector. By harnessing proprietary technology, T2 Biosystems enhances clinical decision-making and improves patient outcomes through timely diagnostics. The company operates both domestically and internationally, positioning itself as a leader in the diagnostic space, particularly amid growing demand for efficient pathogen detection solutions.

VHAI
-25.00%
$0.00
YYAI
-9.13%
$0.18
BURU
+2.87%
$0.47
GWH
+141.86%
$4.16
NVDA
-4.88%
$183.16
STAI
+39.44%
$0.62
BITF
+0.71%
$4.20
CGBS
-39.47%
$0.03
INTC
-3.78%
$36.36
PLUG
-9.52%
$3.42
TLRY
-18.09%
$1.72
RGTI
-6.77%
$43.92
DNN
+1.76%
$2.88
IONZ
+17.18%
$3.41
NIO
-10.05%
$6.71
AMD
-7.72%
$214.90
TSLA
-5.06%
$413.49
APLD
+16.04%
$33.99
SOFI
-7.94%
$26.19
LAES
-11.16%
$5.41
CAN
-10.65%
$1.09
NVTS
+2.87%
$8.23
EPWK
-21.60%
$0.09
DVLT
-16.66%
$1.90
F
-0.78%
$11.41
ETHD
+16.10%
$3.82
MARA
-7.67%
$18.64
GPUS
-9.45%
$0.47
BBD
-4.07%
$3.06
SNAP
-7.15%
$7.78
QS
-1.93%
$14.70
SGBX
+92.59%
$6.24
CIFR
-5.66%
$16.97
IREN
-6.39%
$59.77
AAL
-0.86%
$11.52
AMZN
-4.99%
$216.37
WULF
-0.58%
$13.51
ADAP
-15.99%
$0.18
BMNR
-11.21%
$52.47
AXDX
-61.36%
$0.03
BULL
-9.09%
$11.40
PFE
-1.82%
$24.78
BTBT
-6.46%
$3.76
CLSK
-4.03%
$19.28
AAPL
-3.45%
$245.27
ONDS
-12.10%
$9.22
RXRX
-9.98%
$5.32
WOK
-13.56%
$0.07
ABEV
-1.86%
$2.11
QBTS
-5.84%
$33.02
CRML
+1.83%
$14.98
SOUN
-6.56%
$17.36
PLTR
-5.40%
$175.44
RR
-9.34%
$5.92
QUBT
-10.81%
$19.01
MP
+8.36%
$78.34
PWM
+12.50%
$1.17
RIG
-7.50%
$3.08
GRAB
-5.02%
$5.86
NOK
+2.70%
$5.32
USAR
+4.95%
$32.61
BABA
-8.44%
$159.01
ACHR
-5.45%
$11.97
PTLE
-5.91%
$0.18
BTG
+0.19%
$5.08
UUUU
+3.24%
$20.34
VALE
-2.53%
$10.75
JOBY
-5.01%
$16.28
GDXD
-0.72%
$0.85
SMCI
-8.83%
$52.86
CRWV
-3.24%
$138.43
ASST
-14.08%
$1.55
WBD
-3.22%
$17.10
ATCH
-18.05%
$0.40
NAK
+3.57%
$2.02
ITUB
-2.45%
$6.76
HOOD
-8.85%
$138.96
IONQ
-8.83%
$70.65
RKLB
-3.25%
$64.26
BTE
-8.59%
$2.34
RMBL
+60.50%
$3.21
OKLO
+6.53%
$147.16
SERV
-15.72%
$14.90
ADD
-25.47%
$0.05
VZ
-0.71%
$39.85
JD
-6.24%
$31.85
T
+0.18%
$25.87
CORZ
+2.66%
$18.52
SMR
-3.37%
$39.24
RIOT
-5.70%
$21.01
UAMY
+12.22%
$12.21
HPE
-7.04%
$24.40
TMQ
-9.46%
$5.93
SRM
+53.27%
$10.30
INTS
-3.97%
$0.30
GOOGL
-2.05%
$236.57
HBAN
-4.52%
$15.60
UEC
+8.11%
$14.65
HIMS
-7.38%
$53.95
BAC
-2.28%
$48.65
VHAI
-25.00%
$0.00
YYAI
-9.13%
$0.18
BURU
+2.87%
$0.47
GWH
+141.86%
$4.16
NVDA
-4.88%
$183.16
STAI
+39.44%
$0.62
BITF
+0.71%
$4.20
CGBS
-39.47%
$0.03
INTC
-3.78%
$36.36
PLUG
-9.52%
$3.42
TLRY
-18.09%
$1.72
RGTI
-6.77%
$43.92
DNN
+1.76%
$2.88
IONZ
+17.18%
$3.41
NIO
-10.05%
$6.71
AMD
-7.72%
$214.90
TSLA
-5.06%
$413.49
APLD
+16.04%
$33.99
SOFI
-7.94%
$26.19
LAES
-11.16%
$5.41
CAN
-10.65%
$1.09
NVTS
+2.87%
$8.23
EPWK
-21.60%
$0.09
DVLT
-16.66%
$1.90
F
-0.78%
$11.41
ETHD
+16.10%
$3.82
MARA
-7.67%
$18.64
GPUS
-9.45%
$0.47
BBD
-4.07%
$3.06
SNAP
-7.15%
$7.78
QS
-1.93%
$14.70
SGBX
+92.59%
$6.24
CIFR
-5.66%
$16.97
IREN
-6.39%
$59.77
AAL
-0.86%
$11.52
AMZN
-4.99%
$216.37
WULF
-0.58%
$13.51
ADAP
-15.99%
$0.18
BMNR
-11.21%
$52.47
AXDX
-61.36%
$0.03
BULL
-9.09%
$11.40
PFE
-1.82%
$24.78
BTBT
-6.46%
$3.76
CLSK
-4.03%
$19.28
AAPL
-3.45%
$245.27
ONDS
-12.10%
$9.22
RXRX
-9.98%
$5.32
WOK
-13.56%
$0.07
ABEV
-1.86%
$2.11
QBTS
-5.84%
$33.02
CRML
+1.83%
$14.98
SOUN
-6.56%
$17.36
PLTR
-5.40%
$175.44
RR
-9.34%
$5.92
QUBT
-10.81%
$19.01
MP
+8.36%
$78.34
PWM
+12.50%
$1.17
RIG
-7.50%
$3.08
GRAB
-5.02%
$5.86
NOK
+2.70%
$5.32
USAR
+4.95%
$32.61
BABA
-8.44%
$159.01
ACHR
-5.45%
$11.97
PTLE
-5.91%
$0.18
BTG
+0.19%
$5.08
UUUU
+3.24%
$20.34
VALE
-2.53%
$10.75
JOBY
-5.01%
$16.28
GDXD
-0.72%
$0.85
SMCI
-8.83%
$52.86
CRWV
-3.24%
$138.43
ASST
-14.08%
$1.55
WBD
-3.22%
$17.10
ATCH
-18.05%
$0.40
NAK
+3.57%
$2.02
ITUB
-2.45%
$6.76
HOOD
-8.85%
$138.96
IONQ
-8.83%
$70.65
RKLB
-3.25%
$64.26
BTE
-8.59%
$2.34
RMBL
+60.50%
$3.21
OKLO
+6.53%
$147.16
SERV
-15.72%
$14.90
ADD
-25.47%
$0.05
VZ
-0.71%
$39.85
JD
-6.24%
$31.85
T
+0.18%
$25.87
CORZ
+2.66%
$18.52
SMR
-3.37%
$39.24
RIOT
-5.70%
$21.01
UAMY
+12.22%
$12.21
HPE
-7.04%
$24.40
TMQ
-9.46%
$5.93
SRM
+53.27%
$10.30
INTS
-3.97%
$0.30
GOOGL
-2.05%
$236.57
HBAN
-4.52%
$15.60
UEC
+8.11%
$14.65
HIMS
-7.38%
$53.95
BAC
-2.28%
$48.65
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.